|
1
|
Araghi M, Soerjomataram I, Jenkins M,
Brierley J, Morris E, Bray F and Arnold M: Global trends in
colorectal cancer mortality: Projections to the year 2035. Int J
Cancer. 144:2992–3000. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Benedix F, Kube R, Meyer F, Schmidt U,
Gastinger I and Lippert H; Colon/Rectum Carcinomas (Primary Tumor)
Study Group, : Comparison of 17,641 patients with right- and
left-sided colon cancer: Differences in epidemiology perioperative
course, histology, and survival. Dis Colon Rectum. 53:57–64. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Alexiusdottir KK, Möller PH, Snaebjornsson
P, Jonasson L, Olafsdottir EJ, Björnsson ES, Tryggvadottir L and
Jonasson JG: Association of symptoms of colon cancer patients with
tumor location and TNM tumor stage. Scand J Gastroenterol.
47:795–801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hansen IO and Jess P: Possible better
long-term survival in left versus right-sided colon cancer-a
systematic review. Dan Med J. 59:A44442012.PubMed/NCBI
|
|
5
|
Solé X, Crous-Bou M, Cordero D, Olivares
D, Guinó E, Sanz-Pamplona R, Rodriguez-Moranta F, Sanjuan X, de Oca
J, Salazar R and Moreno V: Discovery and validation of new
potential biomarkers for early detection of colon cancer. PLoS One.
9:e1067482014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thorsteinsson M, Kirkeby LT, Hansen R,
Lund LR, Sørensen LT, Gerds TA, Jess P and Olsen J: Gene expression
profiles in stages II and III colon cancers: Application of a
128-gene signature. Int J Colorectal Dis. 27:1579–1586. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Birnbaum DJ, Laibe S, Ferrari A, Lagarde
A, Fabre AJ, Monges G, Birnbaum D and Olschwang S; COL2 Project, :
Expression profiles in stage II colon cancer according to APC gene
status 1 2. Transl Oncol. 5:72–76. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fischer H, Stenling R, Rubio C and
Lindblom A: Colorectal carcinogenesis is associated with stromal
expression of COL11A1 and COL5A2. Carcinogenesis. 22:875–878. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fischer H, Salahshor S, Stenling R, Björk
J, Lindmark G, Iselius L, Rubio C and Lindblom A: COL11A1 in FAP
polyps and in sporadic colorectal tumors. Bmc Cancer. 1:172001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bowen KB, Reimers AP, Luman S, Kronz JD,
Fyffe WE and Oxford JT: Immunohistochemical localization of
collagen type XI alpha1 and alpha2 chains in human colon tissue. J
Histochem Cytochem. 56:275–283. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Badea L, Herlea V, Dima SO, Dumitrascu T
and Popescu I: Combined gene expression analysis of whole-tissue
and microdissected pancreatic ductal adenocarcinoma identifies
genes specifically overexpressed in tumor epithelia.
Hepatogastroenterology. 55:2016–2027. 2008.PubMed/NCBI
|
|
12
|
Chong IW, Chang MY, Chang HC, Yu YP, Sheu
CC, Tsai JR, Hung JY, Chou SH, Tsai MS, Hwang JJ and Lin SR: Great
potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1
markers for diagnosis of patients with non-small cell lung cancer.
Oncol Rep. 16:981–988. 2006.PubMed/NCBI
|
|
13
|
Feng Y, Sun B, Li X, Zhang L, Niu Y, Xiao
C, Ning L, Fang Z, Wang Y, Zhang L, et al: Differentially expressed
genes between primary cancer and paired lymph node metastases
predict clinical outcome of node-positive breast cancer patients.
Breast Cancer Res Treat. 103:319–329. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu YH, Chang TH, Huang YF, Huang HD and
Chou CY: COL11A1 promotes tumor progression and predicts poor
clinical outcome in ovarian cancer. Oncogene. 33:3432–3440. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sok JC, Lee JA, Dasari S, Joyce S,
Contrucci SC, Egloff AM, Trevelline BK, Joshi R, Kumari N, Grandis
JR and Thomas SM: Collagen type XI α1 facilitates head and neck
squamous cell cancer growth and invasion. Br J Cancer.
109:3049–3056. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu YH, Chang TH, Huang YF, Chen CC and
Chou CY: COL11A1 confers chemoresistance on ovarian cancer cells
through the activation of Akt/c/EBPβ pathway and PDK1
stabilization. Oncotarget. 6:23748–23763. 2015.PubMed/NCBI
|
|
17
|
Galván JA, García-Martínez J,
Vázquez-Villa F, García-Ocaña M, García-Pravia C,
Menéndez-Rodríguez P, González-del Rey C, Barneo-Serra L and de los
Toyos JR: Validation of COL11A1/procollagen 11A1 expression in
TGF-β1-activated immortalised human mesenchymal cells and in
stromal cells of human colon adenocarcinoma. BMC Cancer.
14:8672014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brabletz T: EMT and MET in metastasis:
Where are the cancer stem cells? Cancer Cell. 22:699–701. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Eide T, Ramberg H, Glackin C, Tindall D
and Taskén KA: TWIST1, A novel androgen-regulated gene, is a target
for NKX3-1 in prostate cancer cells. Cancer Cell Int. 13:42013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qin Q, Xu Y, He T, Qin C and Xu J: Normal
and disease-related biological functions of Twist1 and underlying
molecular mechanisms. Cell Res. 22:90–106. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Salerno P, Garcia-Rostan G, Piccinin S,
Bencivenga TC, Di Maro G, Doglioni C, Basolo F, Maestro R, Fusco A,
Santoro M and Salvatore G: TWIST1 plays a pleiotropic role in
determining the anaplastic thyroid cancer phenotype. J Clin
Endocrinol Metab. 96:E772–E781. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee KW, Kim JH, Han S, Sung CO, Do IG, Ko
YH, Um SH and Kim SH: Twist1 Is an independent prognostic factor of
esophageal squamous cell carcinoma and associated with its
epithelial-mesenchymal transition. Ann Surg Oncol. 19:326–335.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD
and Wang LH: Twist transcriptionally up-regulates AKT2 in breast
cancer cells leading to increased migration, invasion, and
resistance to paclitaxel. Cancer Res. 67:1979–1987. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hung JJ, Yang MH, Hsu HS, Hsu WH, Liu JS
and Wu KJ: Prognostic significance of hypoxia-inducible
factor-1alpha, TWIST1 and Snail expression in resectable non-small
cell lung cancer. Thorax. 64:1082–1089. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yan-Qi Z, Xue-Yan G, Shuang H, Yu C,
Fu-Lin G, Fei-Hu B, Shi-Ren S, Xu Feng W, Jie D and Dai-Ming F:
Expression and significance of TWIST basic helix-loop-helix protein
over-expression in gastric cancer. Pathology. 39:470–475. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Satoh K, Hamada S, Kimura K, Kanno A,
Hirota M, Umino J, Fujibuchi W, Masamune A, Tanaka N, Miura K, et
al: Up-regulation of MSX2 enhances the malignant phenotype and is
associated with twist 1 expression in human pancreatic cancer
cells. Am J Pathol. 172:926–939. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Matsuo N, Shiraha H, Fujikawa T, Takaoka
N, Ueda N, Tanaka S, Nishina S, Nakanishi Y, Uemura M, Takaki A, et
al: Twist expression promotes migration and invasion in
hepatocellular carcinoma. Bmc Cancer. 9:2402009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matsusaka S, Zhang W, Cao S, Hanna DL,
Sunakawa Y, Sebio A, Ueno M, Yang D, Ning Y, Parekh A, et al:
TWIST1 polymorphisms predict survival in patients with metastatic
colorectal cancer receiving first-line bevacizumab plus
oxaliplatin-based chemotherapy. Mol Cancer Ther. 15:1405–1411.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Missaoui N, Hmissa S, Trabelsi A, Traoré
C, Mokni M, Dante R and Frappart L: Promoter hypermethylation of
CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions
of the uterine cervix. Pathol Res Pract. 207:37–42. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tran PT, Shroff EH, Burns TF, Thiyagarajan
S, Das ST, Zabuawala T, Chen J, Cho YJ, Luong R, Tamayo P, et al:
Twist1 suppresses senescence programs and thereby accelerates and
maintains mutant kras-induced lung tumorigenesis. PLoS Genet.
8:e10026502012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ruppenthal RD, Nicolini C, Filho AF,
Meurer R, Damin AP, Rohe A, Alexandre CO and Damin DC: TWIST1
promoter methylation in primary colorectal carcinoma. Pathol Oncol
Res. 17:867–872. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao N, Sun BC, Zhao XL, Liu ZY, Sun T,
Qiu ZQ, Gu Q, Che N and Dong XY: Coexpression of Bcl-2 with
epithelial-mesenchymal transition regulators is a prognostic
indicator in hepatocellular carcinoma. Med Oncol. 29:2780–2792.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
World Medical Association Inc, .
Declaration of Helsinki. Ethical principles for medical research
involving human subjects. J Indian Med Assoc. 107:403–405.
2009.PubMed/NCBI
|
|
34
|
Council for International Organizations of
Medical Sciences, . International ethical guidelines for biomedical
research involving human subjects. Bull Med Ethics. 10:17–23.
2002.
|
|
35
|
Bankowski Z: Council for International
Organizations of Medical Sciences. J Med Imag Radiation Oncol.
15:83–87. 1971.
|
|
36
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: Affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Smyth GK: LIMMA: Linear models for
microarray dataBioinformatics and Computational Biology Solutions
Using R and Bioconductor. Gentleman R, Carey V, Dudoit S, Irizarry
R and Huber W: Statistics for Biology and Health. Springer; New
York, NY: pp. 397–420. 2005, View Article : Google Scholar
|
|
38
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43:D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Franceschini A, Szklarczyk D, Frankild S,
Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C
and Jensen LJ: STRING v9. 1: Protein-protein interaction networks,
with increased coverage and integration. Nucleic Acids Res.
41:D808–D815. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mizuno H, Kitada K, Nakai K and Sarai A:
PrognoScan: A new database for meta-analysis of the prognostic
value of genes. BMC Med Genomics. 2:182009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Weiss HL, Niwas S, Grizzle WE and
Piyathilake C: Receiver operating characteristic (ROC) to determine
cut-off points of biomarkers in lung cancer patients. Dis Markers.
19:273–278. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization, and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wu YH, Huang YF, Chang TH and Chou CY:
Activation of TWIST1 by COL11A1 promotes chemoresistance and
inhibits apoptosis in ovarian cancer cells by modulating
NF-κB-mediated IKKβ expression. Int J Cancer. 141:2305–2317. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bufill JA: Colorectal cancer: Evidence for
distinct genetic categories based on proximal or distal tumor
location. Ann Intern Med. 113:779–788. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Nitsche U, Stögbauer F, Späth C, Haller B,
Wilhelm D, Friess H and Bader FG: Right sided colon cancer as a
distinct histopathological subtype with reduced prognosis. Dig
Surg. 33:157–163. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Venook AP, Ou FS, Lenz HJ, Kabbarah O, QU
X and Niedzwiecki D: Primary (1°) tumor location as an independent
prognostic marker from molecular features for overall survival (OS)
in patients (pts) with metastatic colorectal cancer (mCRC):
Analysis of CALGB/SWOG 80405 (Alliance). J Clin Oncol. 35:3503.
2017. View Article : Google Scholar
|
|
48
|
von Einem JC, Heinemann V, von Weikersthal
LF, Vehling-Kaiser U, Stauch M, Hass HG, Decker T, Klein S, Held S,
Jung A, et al: Left-sided primary tumors are associated with
favorable prognosis in patients with KRAS codon 12/13 wild-type
metastatic colorectal cancer treated with cetuximab plus
chemotherapy: An analysis of the AIO KRK-0104 trial. J Cancer Res
Clin Oncol. 140:1607–1614. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Brulé SY, Jonker DJ, Karapetis CS,
O'Callaghan CJ, Moore MJ, Wong R, Tebbutt NC, Underhill C, Yip D,
Zalcberg JR, et al: Location of colon cancer (right-sided versus
left-sided) as a prognostic factor and a predictor of benefit from
cetuximab in NCIC CO.17. Eur J Cancer. 51:1405–1414. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Shen H, Yang J, Huang Q, Jiang MJ, Tan YN,
Fu JF, Zhu LZ, Fang XF and Yuan Y: Different treatment strategies
and molecular features between right-sided and left-sided colon
cancers. World J Gastroenterol. 21:6470–6478. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kim GP, Colangelo LH, Wieand HS, Paik S,
Kirsch IR, Wolmark N and Allegra CJ; National Cancer Institute, :
Prognostic and predictive roles of high-degree microsatellite
instability in colon cancer: A national cancer institute-national
surgical adjuvant breast and bowel project collaborative study. J
Clin Oncol. 25:767–772. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Minoo P, Zlobec I, Peterson M, Terracciano
L and Lugli A: Characterization of rectal, proximal and distal
colon cancers based on clinicopathological, molecular and protein
profiles. Int J Oncol. 37:707–718. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Deng G, Kakar S, Tanaka H, Matsuzaki K,
Miura S, Sleisenger MH and Kim YS: Proximal and distal colorectal
cancers show distinct gene-specific methylation profiles and
clinical and molecular characteristics. Eur J Cancer. 44:1290–1301.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yamauchi M, Morikawa T, Kuchiba A, Imamura
Y, Qian ZR, Nishihara R, Liao X, Waldron L, Hoshida Y, Huttenhower
C, et al: Assessment of colorectal cancer molecular features along
bowel subsites challenges the conception of distinct dichotomy of
proximal versus distal colorectum. Gut. 61:847–854. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Phipps AI, Lindor NM, Jenkins MA, Baron
JA, Win AK, Gallinger S, Gryfe R and Newcomb PA: Colon and rectal
cancer survival by tumor location and microsatellite instability:
The Colon Cancer Family Registry. DisColon Rectum. 56:937–944.
2013. View Article : Google Scholar
|
|
56
|
Loree JM, Pereira AAL, Lam M, Willauer AN,
Raghav K, Dasari A, Morris VK, Advani S, Menter DG, Eng C, et al:
Classifying colorectal cancer by tumor location rather than
sidedness highlights a continuum in mutation profiles and consensus
molecular subtypes. Clin Cancer Res. 24:1062–1072. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Liu F, Li C, Jia H, Yang L, Wu Y, Zhao J,
Cai S, Zhu J and Xu Y: Is there a prognostic value of tumor
location among Chinese patients with colorectal cancer? Oncotarget.
8:38682–38692. 2017.PubMed/NCBI
|
|
58
|
Slattery ML, Curtin K, Wolff RK, Boucher
KM, Sweeney C, Edwards S, Caan BJ and Samowitz W: A comparison of
colon and rectal somatic DNA alterations. DisColon Rectum.
52:1304–1311. 2009. View Article : Google Scholar
|
|
59
|
Liotta LA, Rao CN and Barsky SH: Tumor
invasion and the extracellular matrix. Lab Invest. 49:636–649.
1983.PubMed/NCBI
|
|
60
|
Mio F, Chiba K, Hirose Y, Kawaguchi Y,
Mikami Y, Oya T, Mori M, Kamata M, Matsumoto M, Ozaki K, et al: A
Functional Polymorphism in COL11A1, which encodes the alpha 1 chain
of type XI collagen, is Associated with Susceptibility to Lumbar
Disc Herniation. Am J Hum Genet. 81:1271–1277. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Barkan D, Green JE and Chambers AF:
Extracellular matrix: A gatekeeper in the transition from dormancy
to metastatic growth. Eur J Cancer. 46:1181–1188. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Hynes RO: The Extracellular Matrix: Not
Just Pretty Fibrils. Science. 326:1216–1219. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Raglow Z and Thomas SM: Tumor matrix
protein collagen XIα1 in cancer. Cancer Lett. 357:448–453. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Egeblad M, Rasch MG and Weaver VM: Dynamic
interplay between the collagen scaffold and tumor evolution. Curr
Opin Cell Biol. 22:697–706. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Prockop DJ, Kivirikko KI, Tuderman L and
Guzman NA: The biosynthesis of collagen and its disorders (second
of two parts). N Engl J Med. 301:77–85. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Li Y, Lacerda DA, Warman ML, Beier DR,
Yoshioka H, Ninomiya Y, Oxford JT, Morris NP, Andrikopoulos K,
Ramirez F, et al: A fibrillar collagen gene, Col11a1, is essential
for skeletal morphogenesis. Cell. 80:423–430. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Donoso LA, Edwards AO, Frost AT, Ritter R
III, Ahmad N, Vrabec T, Rogers J, Meyer D and Parma S: Clinical
variability of Stickler syndrome: role of exon 2 of the collagen
COL2A1 gene. Surv Ophthalmol. 48:191–203. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Annunen S, Körkkö J, Czarny M, Warman ML,
Brunner HG, Kääriäinen H, Mulliken JB, Tranebjaerg L, Brooks DG,
Cox GF, et al: Splicing mutations of 54-bp exons in the COL11A1
gene cause marshall syndrome, but other mutations cause overlapping
marshall/stickler phenotypes. Am J Hum Genet. 65:974–983. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Ma C, Rong Y, Radiloff DR, Datto MB,
Centeno B, Bao S, Cheng AW, Lin F, Jiang S, Yeatman TJ and Wang XF:
Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of
colon cancer by enhancing cell extravasation. Genes Dev.
22:308–321. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Prieto-García E, Díaz-García CV,
García-Ruiz I and Agulló-Ortuño MT: Epithelial-to-mesenchymal
transition in tumor progression. Med Oncol. 34:1222017. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Kim A, Bae YK, Gu MJ, Kim JY, Jang KY, Bae
HI, Lee HJ and Hong SM: Epithelial-mesenchymal transition phenotype
is associated with patient survival in small intestinal
adenocarcinoma. Pathology. 45:567–573. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Kudo-Saito C, Shirako H, Takeuchi T and
Kawakami Y: Cancer metastasis is accelerated through
immunosuppression during Snail-induced EMT of cancer cells. Cancer
Cell. 15:195–206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Burk U, Schubert J, Wellner U, Schmalhofer
O, Vincan E, Spaderna S and Brabletz T: A reciprocal repression
between ZEB1 and members of the miR-200 family promotes EMT and
invasion in cancer cells. Embo Rep. 9:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Wahl GM: BS1-1: Stem cells, cancer, and
cancer stem cells. Cancer Res. 71:BS12011.
|
|
76
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Yang J, Mani SA, Donaher JL, Ramaswamy S,
Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and
Weinberg RA: Twist, a master regulator of morphogenesis, plays an
essential role in tumor metastasis. Cell. 117:927–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Zhu DJ, Chen XW, Zhang WJ, Wang JZ, Ouyang
MZ, Zhong Q and Liu CC: Twist1 is a potential prognostic marker for
colorectal cancer and associated with chemoresistance. Am J Cancer
Res. 5:2000–2011. 2015.PubMed/NCBI
|
|
79
|
Puisieux A, Valsesia-Wittmann S and
Ansieau S: A twist for survival and cancer progression. Br J
Cancer. 94:13–17. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Firulli AB and Conway SJ:
Phosphoregulation of Twist1 provides a mechanism of cell fate
control. Curr Med Chem. 15:2641–2647. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Fu J, Qin L, He T, Qin J, Hong J, Wong J,
Liao L and Xu J: The TWIST/Mi2/NuRD protein complex and its
essential role in cancer metastasis. Cell Res. 21:275–289. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Qin L, Liu Z, Chen H and Xu J: The steroid
receptor coactivator-1 (SRC-1) regulates twist expression and
promotes breast cancer metastasis. Cancer Res. 69:3819–3827. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Vernon AE and LaBonne C: Tumor metastasis:
A new twist on epithelial-mesenchymal transitions. Curr Biol.
14:R719–R721. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Karreth F and Tuveson DA: Twist induces an
epithelial-mesenchymal transition to facilitate tumor metastasis.
Cancer Biol Ther. 3:1058–1059. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Yang J, Mani SA and Weinberg RA: Exploring
a new twist on tumor metastasis. Cancer Res. 66:4549–4552. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Venook A, Niedzwiecki D, Lenz HJ, et al:
CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin
(FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with
bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS
wild-type (wt) untreated metastatic adenocarcinoma of the colon or
rectum (MCRC). J Clin Oncol. 32:S182014. View Article : Google Scholar
|
